Cidara Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Cidara Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Cidara Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $400K, a 33.3% increase year-over-year.
  • Cidara Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.3M, a 8.33% increase from 2022.
  • Cidara Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $1.2M, a 20% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $400K +$100K +33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $300K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $300K +$100K +50% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $200K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $200K -$33K -14.2% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-13
Q1 2019 $233K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.